Massachusetts-based care system that started as a grant-funded pilot to integrate medical, behavioral health, and social services for people with significant care needs celebrates 20 years of innovative care BOSTON–(BUSINESS WIRE)–Commonwealth Care Alliance® (CCA), an integrated care system mission-driven to challenge conventional ways of providing care, especially for individuals with complex care needs, has reached … [Read more…]
Product sales increased 15% for the quarter and 41% for the year, driven by increasingly diversified revenue streams Wound care revenue increased 143% year over year Digital marketing program optimization continued to drive higher product sales on lower marketing spend Eyecare portfolio recently expanded with the introduction of the Avenova® oral supplement and Eyeganics Organic … [Read more…]
CARTITUDE-4, a Phase 3 study of CARVYKTI® (ciltacabtagene autoleucel) meets primary endpoint at the study’s first pre-specified interim analysis FDA clearance of IND application for LB2102 in Extensive Stage Small Cell Lung Cancer (SCLC) CARVYKTI® (ciltacabtagene autoleucel) receives approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for the treatment of patients with relapsed … [Read more…]
– Data provide key insights supporting Edgewise’s strategy to advance EDG-5506 for the treatment of Duchenne and Becker muscular dystrophy – BOULDER, Colo.–(BUSINESS WIRE)–Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, targeted, small molecule therapies for the treatment of devastating muscle disorders, today announced the publication of the article, … [Read more…]
Not for distribution to United States newswire services or for dissemination in the United States QUEBEC CITY–(BUSINESS WIRE)–Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, is pleased to announce that at the annual … [Read more…]
Dr. Eric Reiman, nationally recognized Alzheimer’s researcher, selected as new chair PHOENIX–(BUSINESS WIRE)–#Alzheimers–Dr. David Gullen, the longest-serving member of the Flinn Foundation board of directors, is stepping down as chair after 21 years of leading the philanthropic grantmaking organization. He will remain a board member through March 2024 before retiring. Gullen, a physician who practiced … [Read more…]
VANCOUVER, British Columbia–(BUSINESS WIRE)–#education–Please replace the release with the following corrected version due to multiple revisions. The updated release reads: REVITALIST ENTERS INTO NETWORK AGREEMENT FOR SPECIALTY PROVIDERS WITH CORECHOICE (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), CoreChoice has entered into a agreement with Revitalis to participate in their Behavioral Health Network. This relationship will allow … [Read more…]
ATLANTA–(BUSINESS WIRE)–United Digestive (or the “Company”), a leading gastroenterology platform that provides gastrointestinal (“GI”) services within the Southeast United States, announced today a growth capital investment from Kohlberg & Company, LLC (“Kohlberg”), a leading private equity firm based in New York with more than 30 years of experience. Headquartered in Atlanta, Georgia, United Digestive is … [Read more…]
Analysts credit the Oncobiota microbiome-driven liquid biopsy platform for identifying the “infinite potential” of using microbiome markers to diagnose cancer. SAN DIEGO–(BUSINESS WIRE)–Based on an independent team of experts’ rigorous evaluation of a broad field of nominated companies, Frost & Sullivan has selected Micronoma, the first biotech company offering early cancer detection with a microbiome-driven … [Read more…]
MINNEAPOLIS–(BUSINESS WIRE)–After the abrupt closure of a national chain of Ketamine Wellness Centers, including one in the Twin Cities, Advanced Brain + Body Clinic (ABBC) entered into an agreement with the Minneapolis VA to provide care to more than 50 veterans who were left stranded by the closure. Offering hard-to-find treatments including ketamine/esketamine (Spravato) and … [Read more…]
